Centoxin: the full story of its withdrawal.
Choyce
M Q
MQ
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016470:Bacteremia / Q000188:drug therapy / Q000401:mortality; D002986:Clinical Trials as Topic; D004335:Drug and Narcotic Control; D004731:Endotoxins / Q000276:immunology; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000401:mortality; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins; C068069:nebacumab